Nie znaleźliśmy wyników w zadanych kryteriach!
Ale mamy wyniki w innych katalogach.Filtry
wszystkich: 13117
-
Katalog
- Publikacje 4626 wyników po odfiltrowaniu
- Czasopisma 28 wyników po odfiltrowaniu
- Osoby 355 wyników po odfiltrowaniu
- Wynalazki 25 wyników po odfiltrowaniu
- Projekty 15 wyników po odfiltrowaniu
- Laboratoria 6 wyników po odfiltrowaniu
- Zespoły Badawcze 9 wyników po odfiltrowaniu
- Aparatura Badawcza 50 wyników po odfiltrowaniu
- Kursy Online 1919 wyników po odfiltrowaniu
- Wydarzenia 70 wyników po odfiltrowaniu
- Dane Badawcze 6014 wyników po odfiltrowaniu
wyświetlamy 1000 najlepszych wyników Pomoc
Wyniki wyszukiwania dla: HIV-1
-
Inhibition of HIV‐1 or bacterial activation of macrophages by products of HIV‐1‐resistant human cells
Publikacja -
Induction of Secreted Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Factors in CD4-Positive T Lymphocytes by Attenuated HIV-1 Infection
Publikacja -
Value of Perfusion-Weighted MR Imaging in the Assessment of Early Cerebral Alterations in Neurologically Asymptomatic HIV-1-Positive and HCV-Positive Patients
Publikacja -
Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challenge
Publikacja -
Microarray analysis of differentially expressed genes in cells resistant to HIV-1
Publikacja -
Monoubiquitinated Histone H1B Is Required for Antiviral Protection in CD4+T Cells Resistant to HIV-1
Publikacja -
Assessment of urinary cystatin C levels in HIV-1-infected patients with preserved kidney function
Publikacja -
Molecular basis and potential activity of HIV-1 reverse transcriptase toward trimethylamine-based compounds
PublikacjaReverse transcriptase (RT) inhibitors are currently used to treat human immunodeficiency virus (HIV)-1 infections. In this work, novel triethylamine derivatives were designed and studied by rigid and flexible docking and molecular dynamics (MD) approaches. An apo form of HIV-1 RT was also studied by MD simulation to analyze comparative response of protein in ligand-bound and ligand-unbound forms. Among newly designed HIV-1 RT inhibitors,...
-
Extracting functional groups of ALLINI to design derivatives of FDA‐approved drugs: Inhibition of HIV‐1 integrase
PublikacjaHIV‐1 integrase (IN) is crucial for integration of viral DNA into the host genome and a promising target in development of antiretroviral inhibitors. In this work, six new compounds were designed by linking the structures of two different class of HIV‐1 IN inhibitors (active site binders and allosteric IN inhibitors (ALLINIs)). Among newly designed compounds, INRAT10b was found most potent HIV‐1 IN inhibitor considering different...
-
Lancet HIV
Czasopisma